
This study assesses the diagnostic utility of serum inflammatory biomarkers in cases of salivary gland tumours with inconclusive cytological analysis. Analyzing 239 cases from 2011 to 2022, this study identified SIRI as a promising biomarker with an AUC of 0.77 and an accuracy of 79.9%. Combining SIRI with cytological analysis enhances sensitivity to 82.8%, suggesting the potential of inflammatory biomarkers in supporting challenging salivary gland tumour diagnoses.
Like
Save
Share